The 2nd International Conference of Hypertension in Children and Adolescent (ICHCA)

The 2nd International Conference of Hypertension in Children and Adolescent (ICHCA) is organized by Paragon Group and will be held from May 24 - 26, 2019 at Warsaw Marriott Hotel, Warsaw, Mazovia, Poland.

The target audience for this medical event is experts from the fields of:
• Cardiology
• Clinical Trials
• Diabetes
• Nephrology
• Hypertension
• Nutrition
• Internal Medicine
• Obesity
• Dyslipidemia
• Scientists in CV And the metabolic field
• Imaging - Innovative And Routine Methods
• Physical Activity Professionals
• Endocrinology
• CardioMetabolic Syndrome
• Epidemiology
• Pediatricians
• Diagnostics
• Family Medicine

Description:
Hypertension in children and adolescents has shown exponential growth in many countries throughout the world and there is a compelling need to address this epidemic by promoting education, research and scientific exchange. The Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in hypertension in children and adolescents that is relevant to both paediatric and adult internists, cardiologists, nephrologists, endocrinologists, general practitioner, pharmacologists, epidemiologists and scientists.

The ICHCA 2019 Congress has been designed to provide an innovative and comprehensive overview of the latest research developments in hypertension in children and adolescents.

Topics:
• Facing the challenges of hypertension in children and adolescents
• Epidemiology of hypertension in children and adolescents
• Blood pressure tracking and risk from birth to adulthood
• Clustering of cardiometabolic risk factor and ethnic differences in children and adolescents
• Reference values and simplified interpretation of BP in children and adolescents
• 24 hour BP monitoring in children and adolescents
• Understanding the pathogenesis of hypertension in children and adolescents – uric acid and fructose, obesity, environmental pollution, perinatal programming and genetic factors
• Impact of hypertension on the heart and kidneys in children and adolescents
• The importance of white hypertension in children and adolescents
• The value of PWV and central aortic BP in the assessment of target organ damage and risk profiling in children and adolescents
• Treating hypertension in children and adolescents with kidney disease and kidney transplants
• Overview of guidelines for treatment of hypertension in children and adolescents
• Should isolated systolic hypertension in children and adolescents be treated?
• Are trials in children and adolescents with hypertension feasible?
• Novel treatments for hypertension in children and adolescents
• The role of bariatric surgery in children and adolescents
• Psychosocial effects of hypertension in children and adolescents
• An approach to secondary causes of hypertension in children and adolescents
• Renovascular hypertension in children and adolescents
• Mendelian forms of hypertension in children and adolescent

Additional details will be posted as soon as they are available.